Mounjaro face. Ozempic face. The three changes nobody warned you about.

A patient came in last month, six months off Mounjaro, three stone lighter, and the first thing she said before sitting down was, "my husband says my face has aged ten years." She was forty-one. She had lost weight she had wanted to lose for a decade. She did not regret the decision. She did not want to undo it. She wanted to know what could be done about the face, and she wanted someone to be honest about it.

The honest answer is that three things have happened to her face, not one. Most of the conversation online conflates them. Most of the clinical advice she had already been given conflated them. And the standard first move (a syringe of filler in each cheek) addresses only one of the three.

This is a longer read than a marketing page. If you have lost weight on Mounjaro, Ozempic, or Wegovy and you are trying to work out what to do next, here is the clinical picture as I see it, with the references that informed it.

What is actually happening, in plain language

The aesthetic literature has caught up with the phenomenon in the past 18 months. Montecinos and colleagues laid out the dermatologic implications in 2024¹. Haykal and colleagues published a broader review in the Journal of Cosmetic Dermatology last year covering body and skin both². An experience-based set of considerations for non-surgical facial treatment in this group was published in early 2025³. None of these are large randomised trials. They are case series, expert opinion, and structured clinical observation. The evidence base for treating the post-GLP-1 face is, frankly, where the evidence base for treating the post-pregnancy face was twenty years ago. It is real, and it is thin.

What the papers and our own caseload agree on is this: when weight comes off the body, it comes off the face too. The fat pads of the midface (the deep medial cheek fat in particular) thin. The temporal hollows above the cheekbone deepen. The pre-jowl sulcus, the small valley in front of the jowl, becomes more visible. The cheek that used to sit forward and project light now sits flatter, and the shadow falls differently. People register the change as tired or older, even when nothing about the underlying bone has moved a millimetre.

That is change one: volume loss. It is the change everyone names. It is also the easiest to reverse.

The second change is skin elasticity, and it is the one that gets ignored

When fat pads thin slowly across decades, the skin envelope retracts and remodels alongside the loss. The collagen network adjusts. When the same volume of fat leaves the face in nine months instead of nine years, the skin does not have time to do that. The envelope is now a size too big for the structure underneath. You see this as a slight hollowing of the cheek that does not look quite right when the person smiles. You see it as fine vertical lines that were not there a year ago. You see it as a softening of the jawline that is more about the skin sagging across the bone than about any new fat sitting under the chin.

This is not a flaw in the patient. It is biomechanics. Skin elasticity is a finite resource that takes months to rebuild. The treatments that rebuild it (polynucleotides, microneedling with PRP, well-selected radiofrequency, biostimulator injectables) work on a longer clock than filler does. A recent case series of 24 patients treated with sub-dermal radiofrequency over a 12-month follow-up showed measurable improvements in skin laxity scores, with the meaningful gains appearing between months four and nine⁴. That is the cadence to plan against.

If a clinic offers you the post-GLP-1 conversation and the only word they use is filler, they are addressing one third of what changed.

The third change is proportion, and almost nobody talks about it

The face has three thirds. From the hairline to the eyebrow line, the upper third. Eyebrow to the base of the nose, the middle. Nose to chin, the lower. When the midface deflates faster than the lower face (which it does, because the cheek fat pads sit higher than the jowl and chin fat pads do), the proportion shifts. The lower third becomes visually dominant. The eye area starts reading sunken not because the eye has changed but because the cheek beneath it has receded. The jawline reads heavier even when objectively it has narrowed.

Proportional rebalancing is what the published literature on this still calls a "personalised approach" because there is no protocol that works for everyone. In our hands, we deal with proportion last, after volume has been restored and skin quality has had three to six months to recover. The face we are rebalancing in month nine is not the face the patient walked in with in month one. Treating proportion early is how you get the over-filled, over-projected look that has become a meme on TikTok. Treating proportion last, after the rest of the face has settled, is how you get a result that quietly looks like the patient on a good day.

Why one appointment is the wrong unit of planning

In a normal aesthetic consultation, the conversation runs: here is what you want to change, here is the product that does it, here is the price. That works for a single lip enhancement. It does not work here.

The clinical reality is that the three changes resolve on three different timelines.

• Volume can be addressed in a single 30-minute appointment, with peak result visible at two weeks and steady-state at four to six weeks.
• Skin elasticity rebuilds over three to six months of regenerative treatment delivered in courses, not single sessions.
• Proportion needs assessment in motion, not on a still photograph, and is best done after the first two changes have stabilised.

If you book a single appointment, you get the first one only. You leave with a fuller cheek and the same loose skin and the same proportional imbalance. Three months later, when the skin laxity becomes the dominant visual cue, you book another appointment, and someone tells you you need more filler. That is how the over-filled face is built, one well-meant intervention at a time.

What we do not do

We do not run before-and-after photo sets that imply a single treatment caused a 12-month outcome. The protocol is too new in its packaged form for us to have a clean cohort yet. The individual treatment evidence we can show in consultation; the aggregate Post-GLP-1 outcome we will publish when our first cohort hits their twelve-month review later this year.

We do not push patients into starting the protocol while they are still actively losing weight. The literature consensus, and our own preference, is to wait until weight has been stable for at least four weeks. Treating a face that is still mid-transition risks chasing a moving target, and it is not fair on the patient's wallet.

We do not perform anti-wrinkle injections or dermal filler personally as your lead clinician on this protocol. That work, when the volume phase comes, is delivered by Rhianna Beckford (Paramedic) and Vicki Lefeuve (NHS Clinician), under the same protocol. I lead the regenerative and proportion-assessment phases. We sequence in a single hand so the face is read consistently across the year.

How to think about cost

The single biggest piece of pushback I get on the programme is the price. £2,400 upfront is real money. So is six monthly payments of £450. So is the cost of doing it badly, twice. A single, mistimed filler session that has to be partly dissolved and redone costs the patient more than the equivalent of a phase of the protocol, and they end up months behind on skin quality work that should have started in month one.

I tell every patient in consultation: if you only have one decision to make, it is whether you want to spend money on a face that gets worse before it gets better, or money on a face that gets a little better each visit for a year. Filler-only is the first model. A sequenced protocol is the second.

What to ask any London clinic before you book a post-GLP-1 consultation

Three questions tell you whether you are talking to a clinic that has thought about this properly.

One. "What changes have you observed in patients off GLP-1s, beyond volume loss?" If the answer focuses only on cheeks and tear troughs, you have your answer. The clinics doing this well will talk about skin quality, about proportion, about timing relative to your last dose.

Two. "What does your treatment plan look like over the next 6 to 12 months, not just today?" If they cannot describe a sequence, they do not have one. The right answer involves phases, not products.

Three. "Who delivers each phase of the plan?" In a smaller clinic the answer is one or two clinicians who hand over carefully. In a larger clinic the answer is often whoever has availability. The continuity matters here more than it does for a one-off filler appointment. The clinician reading your face in month eleven should know what your face looked like in month one.

If a clinic answers these well and the price they quote is similar to ours, the choice between us comes down to fit. If the price they quote is much lower, ask what is being skipped.

What this article does not cover, and where to read next

This piece is about the face. The same patients often want to talk about the body (loose skin on the arms, abdomen, inner thighs) which is a different conversation involving different modalities, and which we do not deliver at Melatone. I refer those queries on. We are good at the face. We are not equipped to be good at body contouring at scale, and pretending otherwise would not serve the patient.

The piece also does not cover the medication side. Whether to start, continue, pause, or stop a GLP-1 is between you and the GP or specialist who prescribed it. We are not in that loop and do not try to be. We see you after the medical decisions have been made.

If you want to read the underlying science, the citations are below. If you want to read about how we apply it, the full Post-GLP-1 Recovery Programme page walks through the four phases, the pricing structure, and the practitioner handover. If you want to talk to me directly before booking anything, WhatsApp the clinic and ask for me by name.

Arman Zaki is a GMC-registered Physician Associate and co-founder of Melatone Skin Clinic in Battersea. He leads the Post-GLP-1 Recovery Programme and personally delivers the polynucleotides, PRP and microneedling phases of every patient's plan. Read more about Arman.